Latest current assets for MCAD: $7.3M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2023), MCAD shows a current assets of $7.3M. That compares with $23M in the prior-year period — down 68.7% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, MCAD's current assets is now $7.3M (was $23M) — a 68.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Better Therapeutics is outperforming or lagging.
Tracking MCAD's current assets over time shows whether Better Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $7.3M That compares with $23M in the prior-year period — down 68.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current assets page, Stockcircle has Better Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $7.3M) with ownership activity and broader fundamentals.